2533 related articles for article (PubMed ID: 23859953)
1. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice.
Xia N; Daiber A; Habermeier A; Closs EI; Thum T; Spanier G; Lu Q; Oelze M; Torzewski M; Lackner KJ; Münzel T; Förstermann U; Li H
J Pharmacol Exp Ther; 2010 Oct; 335(1):149-54. PubMed ID: 20610621
[TBL] [Abstract][Full Text] [Related]
5. Formation, signaling functions, and metabolisms of nitrated cyclic nucleotide.
Sawa T; Ihara H; Ida T; Fujii S; Nishida M; Akaike T
Nitric Oxide; 2013 Nov; 34():10-8. PubMed ID: 23632125
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
7. Redox function of tetrahydrobiopterin and effect of L-arginine on oxygen binding in endothelial nitric oxide synthase.
Berka V; Yeh HC; Gao D; Kiran F; Tsai AL
Biochemistry; 2004 Oct; 43(41):13137-48. PubMed ID: 15476407
[TBL] [Abstract][Full Text] [Related]
8. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
9. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
[TBL] [Abstract][Full Text] [Related]
10. Impact of exercise training on redox signaling in cardiovascular diseases.
Campos JC; Gomes KM; Ferreira JC
Food Chem Toxicol; 2013 Dec; 62():107-19. PubMed ID: 23978413
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthases: regulation and function.
Förstermann U; Sessa WC
Eur Heart J; 2012 Apr; 33(7):829-37, 837a-837d. PubMed ID: 21890489
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrobiopterin: biochemistry and pathophysiology.
Werner ER; Blau N; Thöny B
Biochem J; 2011 Sep; 438(3):397-414. PubMed ID: 21867484
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
[TBL] [Abstract][Full Text] [Related]
16. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin.
Cardounel AJ; Xia Y; Zweier JL
J Biol Chem; 2005 Mar; 280(9):7540-9. PubMed ID: 15574418
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
[TBL] [Abstract][Full Text] [Related]
18. Essential thiol requirement to restore pterin- or substrate-binding capability and to regenerate native enzyme-type high-spin heme spectra in the Escherichia coli-expressed tetrahydrobiopterin-free oxygenase domain of neuronal nitric oxide synthase.
Sono M; Ledbetter AP; McMillan K; Roman LJ; Shea TM; Masters BS; Dawson JH
Biochemistry; 1999 Nov; 38(48):15853-62. PubMed ID: 10625450
[TBL] [Abstract][Full Text] [Related]
19. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases.
Roe ND; Ren J
Vascul Pharmacol; 2012; 57(5-6):168-72. PubMed ID: 22361333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
